Header Logo

Lela Buckingham

Concepts (169)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
DNA Methylation
6
2022
164
1.790
Why?
Carcinoma, Non-Small-Cell Lung
6
2012
240
1.030
Why?
Carcinogenesis
2
2022
24
0.940
Why?
Adenoma
2
2022
63
0.880
Why?
Lung Neoplasms
6
2012
551
0.870
Why?
Epigenesis, Genetic
3
2021
84
0.840
Why?
DNA Damage
1
2021
30
0.750
Why?
Glioblastoma
1
2021
13
0.750
Why?
Colonic Neoplasms
1
2022
56
0.740
Why?
MicroRNAs
1
2022
49
0.740
Why?
Carcinoma
1
2022
68
0.740
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2021
13
0.700
Why?
Brain Neoplasms
1
2021
94
0.690
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
2021
29
0.680
Why?
Adenocarcinoma
2
2018
140
0.500
Why?
Early Detection of Cancer
1
2016
104
0.470
Why?
Colorectal Neoplasms
3
2021
111
0.430
Why?
Genes, p16
1
2012
4
0.410
Why?
Quinazolines
3
2012
17
0.390
Why?
Germ-Line Mutation
3
2021
15
0.380
Why?
Carcinoma, Squamous Cell
1
2012
172
0.360
Why?
In Situ Hybridization, Fluorescence
4
2020
37
0.340
Why?
Apoptosis Regulatory Proteins
1
2010
11
0.340
Why?
PTEN Phosphohydrolase
1
2010
8
0.340
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2010
15
0.340
Why?
Protein Kinase Inhibitors
2
2007
55
0.340
Why?
Tumor Suppressor Proteins
1
2010
33
0.330
Why?
Aged
15
2021
9060
0.320
Why?
Long Interspersed Nucleotide Elements
2
2021
5
0.320
Why?
Female
17
2021
15234
0.310
Why?
Endometrial Neoplasms
2
2021
26
0.310
Why?
Humans
22
2022
27114
0.300
Why?
Middle Aged
12
2021
9009
0.300
Why?
Ovarian Neoplasms
2
2020
79
0.290
Why?
Chromosomes, Human, Pair 7
1
2007
3
0.280
Why?
Adult
9
2021
7899
0.270
Why?
Age Factors
2
2021
772
0.240
Why?
Biomarkers, Tumor
5
2020
207
0.240
Why?
Breast Neoplasms
2
2020
411
0.230
Why?
Genetic Testing
2
2016
56
0.230
Why?
Male
12
2021
14793
0.230
Why?
DNA Mutational Analysis
3
2020
55
0.220
Why?
DNA Repair Enzymes
2
2016
8
0.220
Why?
GTP Phosphohydrolases
2
2020
6
0.210
Why?
Genes, BRCA1
2
2020
13
0.210
Why?
Adaptor Proteins, Signal Transducing
2
2016
64
0.210
Why?
Proto-Oncogene Proteins p21(ras)
2
2020
21
0.210
Why?
Membrane Proteins
2
2020
169
0.190
Why?
Genes, p53
2
2020
18
0.190
Why?
Cystadenocarcinoma, Serous
1
2021
7
0.180
Why?
Prognosis
3
2018
804
0.180
Why?
DNA Mismatch Repair
2
2021
10
0.180
Why?
Leukemia, Promyelocytic, Acute
1
2020
5
0.180
Why?
Oncogene Proteins, Fusion
1
2020
11
0.170
Why?
Intestinal Mucosa
1
2022
159
0.170
Why?
Survival Rate
2
2012
344
0.170
Why?
Phthalazines
1
2020
7
0.170
Why?
Neoplasm Staging
2
2012
368
0.170
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2020
6
0.170
Why?
Piperazines
1
2020
86
0.160
Why?
Adenocarcinoma, Follicular
1
2018
8
0.150
Why?
Neoplasm Recurrence, Local
3
2021
218
0.150
Why?
DNA-Binding Proteins
2
2021
273
0.150
Why?
Thyroid Gland
1
2018
43
0.150
Why?
Hematopoiesis
1
2018
11
0.150
Why?
Thyroid Neoplasms
1
2018
46
0.150
Why?
Li-Fraumeni Syndrome
1
2018
3
0.150
Why?
Chimerism
1
2018
5
0.150
Why?
BRCA1 Protein
1
2018
5
0.150
Why?
BRCA2 Protein
1
2018
5
0.150
Why?
Chromosomes, Human
1
2018
6
0.150
Why?
Antineoplastic Agents
2
2012
202
0.140
Why?
Genetic Markers
1
2018
34
0.140
Why?
X-linked Nuclear Protein
1
2017
2
0.140
Why?
Perivascular Epithelioid Cell Neoplasms
1
2017
3
0.140
Why?
Adenomatous Polyps
1
2017
4
0.140
Why?
Neoplasms, Multiple Primary
1
2017
40
0.130
Why?
MutL Protein Homolog 1
1
2016
3
0.130
Why?
Mismatch Repair Endonuclease PMS2
1
2016
6
0.130
Why?
MutS Homolog 2 Protein
1
2016
4
0.130
Why?
Adenosine Triphosphatases
1
2016
9
0.130
Why?
Microsatellite Instability
1
2016
12
0.130
Why?
Prostatic Neoplasms
1
2018
115
0.130
Why?
Mutation
5
2018
350
0.130
Why?
ErbB Receptors
4
2012
55
0.130
Why?
Nuclear Proteins
1
2016
86
0.120
Why?
Young Adult
1
2021
2022
0.120
Why?
CpG Islands
2
2017
54
0.120
Why?
Kaplan-Meier Estimate
2
2012
177
0.120
Why?
Aged, 80 and over
4
2020
4818
0.110
Why?
Cervix Mucus
1
2013
4
0.110
Why?
Case-Control Studies
2
2018
589
0.110
Why?
Precancerous Conditions
1
2013
25
0.100
Why?
Promoter Regions, Genetic
2
2010
95
0.100
Why?
Genital Neoplasms, Female
1
2013
15
0.100
Why?
Radiography, Thoracic
1
2012
27
0.100
Why?
Immunohistochemistry
4
2018
374
0.100
Why?
Treatment Outcome
2
2012
3528
0.100
Why?
Tumor Suppressor Protein p53
1
2013
88
0.100
Why?
Brain
1
2021
1641
0.100
Why?
Receptor, IGF Type 1
1
2012
21
0.100
Why?
Pneumonectomy
1
2012
77
0.100
Why?
Illinois
1
2012
250
0.090
Why?
Meiosis
1
2010
1
0.090
Why?
Saccharomyces cerevisiae Proteins
1
2010
14
0.090
Why?
Histone Deacetylases
1
2010
11
0.090
Why?
Saccharomyces cerevisiae
1
2010
22
0.090
Why?
Disease Progression
2
2018
672
0.090
Why?
Repressor Proteins
1
2010
38
0.090
Why?
Transcription, Genetic
1
2010
107
0.090
Why?
Death-Associated Protein Kinases
1
2010
4
0.090
Why?
DNA Modification Methylases
1
2010
4
0.090
Why?
Monomeric GTP-Binding Proteins
1
2010
5
0.090
Why?
Immunoenzyme Techniques
1
2010
31
0.080
Why?
Cadherins
1
2010
34
0.080
Why?
Antigens, CD
1
2010
52
0.080
Why?
Follow-Up Studies
2
2018
1798
0.080
Why?
Neoplasm Proteins
1
2010
55
0.080
Why?
Lung
1
2010
168
0.080
Why?
High-Throughput Nucleotide Sequencing
2
2020
42
0.080
Why?
Cyclooxygenase 2
1
2008
29
0.070
Why?
Gastrointestinal Hemorrhage
1
2008
23
0.070
Why?
Aneuploidy
1
2007
3
0.070
Why?
Polymerase Chain Reaction
1
2007
118
0.070
Why?
Survival Analysis
1
2007
260
0.070
Why?
Gene Expression Regulation, Neoplastic
1
2007
124
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
245
0.060
Why?
Proportional Hazards Models
1
2007
350
0.060
Why?
Logistic Models
1
2007
397
0.060
Why?
Patient Selection
1
2007
196
0.060
Why?
Pilot Projects
2
2020
415
0.060
Why?
Retrospective Studies
3
2020
3542
0.060
Why?
Genetic Predisposition to Disease
2
2018
366
0.050
Why?
Hyperplasia
1
2021
19
0.050
Why?
Checkpoint Kinase 2
1
2020
8
0.040
Why?
Genes, BRCA2
1
2020
10
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2021
87
0.040
Why?
Colonoscopy
1
2021
73
0.040
Why?
Standard of Care
1
2020
13
0.040
Why?
Databases, Factual
1
2021
350
0.040
Why?
Predictive Value of Tests
2
2013
477
0.040
Why?
Proto-Oncogene Proteins B-raf
1
2018
13
0.040
Why?
Galectin 3
1
2018
4
0.040
Why?
Galectins
1
2018
6
0.040
Why?
Amino Acid Substitution
1
2018
22
0.040
Why?
Mutation, Missense
1
2018
25
0.040
Why?
Blood Proteins
1
2018
19
0.040
Why?
ROC Curve
1
2018
142
0.040
Why?
Feasibility Studies
1
2018
216
0.030
Why?
Sensitivity and Specificity
1
2018
478
0.030
Why?
Sequence Analysis, DNA
1
2017
57
0.030
Why?
Time Factors
1
2020
1439
0.030
Why?
Risk Assessment
1
2018
628
0.030
Why?
Neoplasm Grading
1
2013
55
0.030
Why?
Gene Dosage
1
2012
19
0.020
Why?
Phenotype
1
2013
312
0.020
Why?
Gene Expression Regulation, Fungal
1
2010
1
0.020
Why?
Protein Structure, Tertiary
1
2010
62
0.020
Why?
Protein Binding
1
2010
126
0.020
Why?
Signal Transduction
1
2012
446
0.020
Why?
Peptic Ulcer
1
2008
4
0.020
Why?
Celecoxib
1
2008
6
0.020
Why?
Erlotinib Hydrochloride
1
2008
11
0.020
Why?
In Situ Hybridization
1
2008
49
0.020
Why?
Sulfonamides
1
2008
44
0.020
Why?
Disease-Free Survival
1
2008
179
0.020
Why?
Protein-Tyrosine Kinases
1
2007
17
0.020
Why?
Pyrazoles
1
2008
61
0.020
Why?
Clinical Trials as Topic
1
2007
216
0.020
Why?
Buckingham's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (169)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_